NASDAQ
Finch Therapeutics Group, Inc. (FNCH) has a free cash flow growth of -8.34% as of Friday, May 29, 2026. This represents a 138.88% decrease compared to its 12-month average of 21.47%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.